DMart's Next Growth Engine May Not Be Groceries—It Could Be Medicines

For over two decades, DMart has built one of India's most successful retail businesses around a simple formula: everyday low prices, efficient operations and disciplined expansion. Now, the retailer appears to be testing whether that same formula can be replicated in an entirely different category—pharmacy retail.

According to reports, DMart has launched pilot pharmacy counters inside select stores in the Mumbai Metropolitan Region, offering flat 20% discounts on medicines through a shop-in-shop format. The initiative is being run by Reflect Healthcare and Retail Pvt. Ltd., a wholly owned subsidiary of Avenue Supermarts.

Although still at an early stage, the move suggests DMart is exploring a new business vertical that could complement its core supermarket operations while increasing customer visits and improving store productivity.

Why Pharmacy Retail Makes Strategic Sense For DMart

India's organised pharmacy market remains highly fragmented. While thousands of neighbourhood chemists dominate the industry, organised chains and online pharmacies have steadily increased their presence over the past decade.

For DMart, pharmacy retail offers several strategic advantages. Unlike groceries, medicines generate recurring demand throughout the year. Customers buying prescription medicines typically visit pharmacies every month, creating repeat footfall that can also increase purchases across grocery and household categories. The business also aligns well with DMart's existing strengths:

• High-footfall retail locations.

• Efficient supply chain.

• Strong vendor relationships.

• Low-cost operating model.

• Everyday value pricing.

Rather than building standalone pharmacy stores, DMart is leveraging existing supermarkets to minimise additional rental and customer acquisition costs.

The Shop-in-Shop Model Could Become DMart's Biggest Competitive Advantage

Instead of opening separate medical stores, DMart is reportedly allocating dedicated pharmacy space within existing supermarkets.

This strategy offers several operational benefits.

It eliminates the need for acquiring new retail locations.

It allows customers to purchase groceries, personal care products and medicines in a single visit. It also spreads fixed costs such as rent, security and utilities across multiple business categories.

Most importantly, the company can immediately utilise the heavy customer traffic already visiting DMart stores every day. This gives it a significant cost advantage over standalone pharmacy chains and many online pharmacy platforms that spend heavily on customer acquisition and last-mile delivery.

Why A 20% Discount Matters

The reported 20% discount on medicines is likely to attract immediate consumer attention. Price remains one of the biggest factors influencing pharmacy purchases, particularly for patients requiring long-term medication.

By extending its everyday-low-price philosophy to medicines, DMart could create a differentiated value proposition. However, aggressive pricing also raises competitive pressure across the industry.

Neighbourhood chemists may face margin compression, while organised pharmacy chains and e-pharmacies could be forced to respond with stronger pricing or improved customer services.

Financial Opportunity Goes Beyond Medicine Sales

One reason pharmacy retail is attractive is its profitability profile. Industry estimates suggest that pharmacy businesses generally operate with gross margins of around 25–30%, significantly higher than the 7–8% operating margins typically reported by DMart's supermarket business.

While pharmacy operations require qualified pharmacists, regulatory compliance and inventory management, they also offer:

• Higher customer lifetime value.

• Recurring monthly purchases.

• Cross-selling opportunities.

• Better utilisation of store space.

• Stable demand across economic cycles.

If executed efficiently, the category could improve the profitability of existing stores without requiring substantial additional real estate investments.

DMart's Financial Strength Gives It Room To Experiment

Unlike many retail startups, Avenue Supermarts enters this new segment from a position of financial strength. The company operates more than 500 DMart stores across India and has consistently maintained one of the strongest balance sheets in organised retail.

Store Network

500+ stores

Retail Area

20+ million sq. ft.

Annual Revenue

₹65,000–70,000 crore

Net Profit

₹2,700–3,000 crore

Operating Margin

~7–8%

Rather than depending on external funding, DMart generates sufficient operating cash flows to test new retail formats while continuing its store expansion programme. This financial flexibility allows the company to experiment patiently without pressure for rapid nationwide rollouts.

Challenges Still Remain

Despite the opportunity, pharmacy retail presents unique operational complexities. Key challenges include:

• Drug licensing and regulatory compliance.

• Hiring qualified pharmacists.

• Managing prescription medicines.

• Inventory control.

Competition from established pharmacy chains.

Integration with healthcare regulations. Scaling successfully will require more than simply extending DMart's grocery model into healthcare.

The Bottom Line

DMart's pharmacy initiative should be viewed as a long-term strategic experiment rather than a short-term revenue opportunity. The company has repeatedly demonstrated that disciplined execution, operational efficiency and patient expansion can create sustainable competitive advantages.

If the pilot succeeds, pharmacy retail could become another important growth pillar alongside groceries, home essentials and personal care.

More importantly, it signals that India's organised retailers are increasingly looking beyond traditional categories to drive future growth. For DMart, medicines may represent not just another product category, but a way to increase customer loyalty, improve store economics and strengthen its position in one of India's fastest-growing consumer markets.